About Muradnagar Health Complex
Clinical Trials at Muradnagar Health Complex
During the past decade, Muradnagar Health Complex conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Muradnagar Health Complex
According to Clinical.Site data, the most researched conditions in "Muradnagar Health Complex" are
"Chronic Arsenic Poisoning" (2 trials). Many other conditions were trialed in "Muradnagar Health Complex" in a lesser frequency.
Clinical Trials Intervention Types at Muradnagar Health Complex
Most popular intervention types in "Muradnagar Health Complex" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Neem plus propylene glycol plus salicylic acid" (1 trials), "Salicylic acid" (1 trials) and "Vitamin E capsule" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Muradnagar Health Complex
The vast majority of trials in "Muradnagar Health Complex" are
2 trials for "All" genders.
Clinical Trials Status at Muradnagar Health Complex
Currently, there are NaN active trials in "Muradnagar Health Complex".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Muradnagar Health Complex,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Muradnagar Health Complex, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".